A potent opioid-receptor peptide used strictly in analgesic and receptor research.
In the literature, Dermorphin appears most often in work focused on pain research. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.
Dermorphin is catalogued here under powder peptides. Coverage of this compound varies in quality and depth, and much of it remains early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.
Tap a topic to see which peptides are most studied for it.
Atosiban is a synthetic competitive antagonist of the oxytocin receptor, developed to suppress premature uterine contractions. It is used as a tocolytic agent to treat preterm labor.
Beta-endorphin is a naturally occurring peptide from pro-opiomelanocortin, recognized as the body's potent natural painkiller and mood elevator. Researchers study its crucial roles in pain management, stress response, and mood regulation.
Bradykinin is an endogenous nonapeptide that acts as a principal effector molecule of the kallikrein-kinin system. Researchers study its involvement in inflammation, pain, vasodilation, and various physiological processes.
Research use only. This page summarizes areas of published study and is not medical advice. No dosing, protocol, or usage guidance is provided.